How Rheumatoid Arthritis and Depression Fuel Each Other

Health & LifestyleNews
204

Listen to article (english)

Translate to Spanish or other 102 languages!

As of 2021, about 17.9 million people globally were living with rheumatoid arthritis — an autoimmune type of arthritis that causes inflammation in the joints. Image for illustration purposes
As of 2021, about 17.9 million people globally were living with rheumatoid arthritis — an autoimmune type of arthritis that causes inflammation in the joints. Image for illustration purposes

Mega Doctor News

- Advertisement -

Medical News Today

As of 2021, about 17.9 million people globally were living with rheumatoid arthritis — an autoimmune type of arthritis that causes inflammation in the joints. 

Past studies show that rheumatoid arthritis can negatively impact a person’s health by increasing their risk for irreversible joint damage, osteoporosis, heart disease, eye issues, sleeping problems, obesityTrusted Source, and mental health conditions like anxiety and depression.

- Advertisement -

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/rheumatoid-arthritis-depression-two-way-relationship?utm_term=feature&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2026-06-04&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
More Transplant Patients are Surviving, But Many are Still Left Waiting
Next article
Texas Launches $10M Push for Rural Pediatric Telemedicine

More Articles

STHS Dedicating Latest “South Texas Healthy Living” Episode to Arthritis Education, July 26th

More than 58 million U.S. adults are living with doctor-diagnosed arthritis, according to the Centers for Disease Control and Prevention (CDC), making it the nation’s leading cause of disability.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.

Physicians Warn of Rising ER Visits Linked to E-Bikes and Scooters

Mega Doctor News CLEVELAND CLINIC - As electric bikes and scooters grow in...

STHS Heart Ranks Among Nation’s Top Hospitals for Heart Attack Care

Every year, more than 800,000 people in the United States suffer a heart attack, according to the Centers for Disease Control and Prevention, an event that occurs approximately every 40 seconds.
- Advertisement -